Fagron Compounding Services recalls
4 notices naming Fagron Compounding Services as the recalling firm, since February 26, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Sterility
Fagron Compounding Services: norepinephrine Bitartrate and 4 more
Hazard (FDA): Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
FDAMedicines
Fagron Compounding Services: Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic…
Hazard (FDA): Incorrect Product Formulation
FDAMedicines
Sterility
Fagron Compounding Services: bevacizumab
Hazard (FDA): Lack of Assurance of Sterility
FDAMedicines
Sterility
Fagron Compounding Services: fentaNYL Citrate In Sodium Chloride 1600mcg/100mL
Hazard (FDA): Lack of Assurance of Sterility
FDAMedicines